Autopsy report · NCT02393833

IBCSG Trial 22-00 Serum Substudy

“Sufficient statistical power cannot be met due to low samples size”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 years 9 months after it had already started.
• Ran for about 15 years 9 months before it stopped.
• 136 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

ETOP IBCSG Partners Foundation

Sponsor type

University, hospital or other

Conditions

Breast Cancer

Interventions

Blood samples collection

Participants

136

Sites

3

Countries

Italy, Nigeria, Peru

Trials that died the same way

• Feasibility and Potential Effectiveness of a Case Management Intervention for Alcohol Use-Related Problems in Frequent Users of an Emergency Department: a Pilot Study
  “Insufficient accrual rate to achieve expected sample size.” (57% match in meaning)
• VR-Based Preoperative Rehabilitation Program for Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction
  “The sample size is insufficient” (57% match in meaning)
• Short-course Antibiotic Treatment in Gram-positive Cocci Infective Endocarditis
  “Inability to reach the estimated sample size” (57% match in meaning)
• 3-Dimensional Form and Soft Tissue Biomechanics of the Breast
  “Sample size too small for data analysis.” (56% match in meaning)
• Healthy Relationships and Economic Pathways
  “Recruitment too low for power analysis” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.